AnGes Inc

AJW

Company Profile

  • Business description

    AnGes Inc is a biopharmaceutical company. The company's development projects include - HGF plasmid, NFkB decoy oligonucleotide, and Therapeutic vaccine.

  • Contact

    7-7-15, Saito-asagi
    4F, Saito Bio-Incubator
    Ibaraki
    Osaka567-0085
    JPN

    http://www.anges.co.jp

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    154

Stocks News & Analysis

stocks

Berkshire Hathaway earnings: Cash stockpile hits record; Share repurchases nonexistent

Maintaining our fair value estimate on Berkshire stock.
stocks

New ASX share on our Global Equity Best Ideas

This undervalued share provides the opportunity for investors that look beyond the markets short-sighted view. 
stocks

Undervalued ASX share pulls a rabbit out of a hat

First quarter results are strong and debt levels have dropped.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,394.6028.20-0.33%
CAC 407,371.7137.40-0.50%
DAX 4019,147.85107.12-0.56%
Dow JONES (US)41,794.60257.59-0.61%
FTSE 1008,184.247.090.09%
HKSE20,823.36255.841.24%
NASDAQ18,179.9859.93-0.33%
Nikkei 22538,567.63513.961.35%
NZX 50 Index12,658.3067.700.54%
S&P 5005,712.6916.11-0.28%
S&P/ASX 2008,137.7026.90-0.33%
SSE Composite Index3,369.7059.491.80%

Market Movers